Trials in Progress Poster Session: Hepatobiliary, Neuroendocrine/Carcinoid, Pancreatic & other GI Cancer

Hepatobiliary Cancer: Go to 11 Presentations

Neuroendocrine/Carcinoid: Go to 2 Presentations

Pancreatic Cancer: Go to 10 Presentations

Brian Hemendra Ramnaraign, Steven J. Hughes, Kathryn Hitchcock, et al.

Authors conclusion: Enrollment continues to a maximum of 28 evaluable pts to demonstrate a reduction in historical 30 day postoperative complication rate. NCT03483038


Other GI Cancer: Go to 2 Presentations